Predictors of ovulatory failure in women with epilepsy

Annals of Neurology

Volumn 52, Issue 6, 2002, Pages 704-711

  Morrell, Martha J ^a,c   Giudice, Linda ^b   Flynn, Kerry L ^a   Seale, Cairn G ^b   Paulson, Amelia J ^b   Doñe, Silvia ^a   Flaster, Edith ^a   Ferin, Michel ^a   Sauer, Mark V ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b STANFORD UNIVERSITY   (United States)

^c NEUROLOGICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; GABAPENTIN; LAMOTRIGINE; LUTEINIZING HORMONE; PHENOBARBITAL; PHENYTOIN; TESTOSTERONE; VALPROIC ACID;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENERALIZED EPILEPSY; HUMAN; HYPERANDROGENISM; MAJOR CLINICAL STUDY; OVARY INSUFFICIENCY; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; TRANSVAGINAL ECHOGRAPHY;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; ANOVULATION; ANTICONVULSANTS; CHI-SQUARE DISTRIBUTION; EPILEPSY; FEMALE; HUMANS; OVULATION; PROGNOSIS; VALPROIC ACID;

EID: 0345725866     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.10391     Document Type: Article

References (30)

1. Isojarvi JIT, Laatikainen TJ, Pakarinen AJ, et al. Polycystic appearing ovaries and hyperandrogenism in women taking valproate for epilepsy. N Engl J Med 1993;329:1383-1388.
2. Lobo RA. A disorder without identity: "HCA", "PCAO", "PCAOD," "PCAOS," "SLS". What are we to call it?!. Fertil Steril 1995;63:1158-1160.
3. Reutens DC, Howell RA, Gebert KE, Berkovic SF. Validation of a questionnaire for clinical seizure diagnosis. Epilepsia 1992;33:1065-1071.
4. Ardaens Y, Robert Y, Lemaitre L, et al. Polycystic ovarian disease: Contribution of vaginal endosonography and reassessment of ultrasonic diagnosis. Fertil Steril 1991;55:1062-1068.
5. Fleiss JL. Statistical Methods for Rates and Proportions. New York: Wiley, 1981.
6. Morrell MJ, Flynn KL, Seale CG, et al. Reproductive dysfunction in women with epilepsy: Antiepileptic drug effects on sex-steroid hormones. CNS Spectrums 2001;6:771-785.
7. Morrell MJ, Sperling MR, Stecker M, Dichter MA. Sexual dysfunction in partial epilepsy: A deficit in physiological sexual arousal. Neurology 1994;44:243-247.
8. Morrell MJ, Guldner GT. Self-reported sexual function and sexual arousability in women with epilepsy. Epilepsia 1996;37:1204-1210.
9. Wallace H, Shorvon S, Tallis R. Age-specific incidence and prevalence rates of treated epilepsy in an unselected population of 2,052,922 and age-specific fertility rates of women with epilepsy. Lancet 1998;352:1970-1973.
10. Schupf N, Ottman R. Likelihood of pregnancy in individuals with idiopathic/cryptogenic epilepsy: Social and biologic influence. Epilepsia 1994;35:750-756.
11. Schupf N, Ottman R. Reproduction among individuals with idiopathic/cryptogenic epilepsy: Risk factors for reduced fertility in marriage. Epilepsia 1996;37:833-840.
12. Cummings LN, Giudice L, Morrell MJ. Ovulatory function in epilepsy. Epilepsia 1995;36:355-359.
13. Herzog AG, Russell V, Vartukaitis JL, Geschwin N. Neuroendocrine dysfunction in temporal lobe epilepsy. Arch Neuro L 1982;39:133-135.
14. Herzog AG, Seibel MM, Schomer DL, et al. Reproductive endocrine disorders in women with partial seizures of temporal lobe origin. Arch Neurol 1986;43:347-350.
15. Meo R, Bilo L, Nappi C, et al. Derangement of the hypothalamic GnRH pulse generator in women with epilepsy. Seizure 1993;2:241-252.
16. Drislane FW, Coleman AE, Schomer DL, et al. Altered pulsatile secretion of luteinizing hormone in women with epilepsy. Neurology 1994;44:306-310.
17. Clayton RN, Ogden V, Hodgkinson J, et al. How common are polycystic appearing ovaries in normal women and what is their significance for the fertility of the population? Clin Endocrinol 1992;37:127-134.
18. Ben-Shlomo I, Franks S, Adashi EY. The polycystic ovary syndrome: Nature or nurture? Fertil Steril 1995;63:953-954.
19. Murialdo G, Galimbeti CA, Gianelli MV, et al. Effects of valproate, phenobarbital, and carbamazepine on sex steroid setup in women with epilepsy. Clin Neuropharmacol 1998;21:52-58.
20. Barragry JM, Makin HL, Trafford DJ, Scott DF. Effect of anticonvulsants on plasma testosterone and sex hormone binding globulin levels. J Neurol Neurosurg Psychiatry 1978;41:913-914.
21. Dana-Haeri J, Oxley J. Reduction of free testosterone by antiepileptic drugs. Br Med J 1982;284:85-86.
22. Luhdorf K. Endocrine function and antiepileptic treatment. Acta Neurol Scand 1983;67(suppl 94):15-19.
23. Beastall GH, Cowan RA, Gray JM, Fogelman I. Hormone binding globulins and anticonvulsant therapy. Scott Med J 1985;30:101-105.
24. Pasquali R, Cassimirri F. The impact of obesity on hyperandrogenism and polycystic ovary syndrome in premenopausal women. Clin Endocrinol 1993;39:1-16.
25. Deslypere JP, Verdonck L, Vermeulen A. Fat tissue: A steroid reservoir and site of endocrine metabolism. J Clin Endocrinol Metab 1985;61:564-570.
26. Devinsky O, Vuong A, Hammer A, et al. Stable weight during lamotrigine therapy: A review of 32 studies. Neurology 2000;54:973-975.
27. Biton V, Mirza W, Montouris G, et al. Weight change associated with valproate and lamotrigine monotherapy in patients with epilepsy. Neurology 2001;56:172-177.
28. Isojarvi JIT, Laatikainen TJ, Knip M, et al. Obesity and endocrine disorders in women taking valproate for epilepsy. Ann Neurol 1996;39:579-584.
29. Isojarvi JIT, Rattya J, Myllyla VV, et al. Valproate, lamotrigine and insulin mediated risks in women with epilepsy. Ann Neurol 1998;43:446-451.
30. Herzog AG. Polycystic ovarian syndrome in women with epilepsy: Epileptic or iatrogenic? Ann Neurol 1996;39:559-560.